Budi Starch Sweetener Tbk vs Multi Medika Internasional Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 926.79B, 1.3K 24h volume), while Multi Medika Internasional Tbk. trades at Rp760 (market cap 3.72T, 39.48M 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 4× Budi Starch Sweetener Tbk's market cap, and Multi Medika Internasional Tbk. is more actively traded (39.48M versus 1.3K). Which is the better fit depends on your goals.
| BUDI | MMIX | |
|---|---|---|
Market Cap | 926.79B | 3.72T |
Volume | 1.3K | 39.48M |
Lot | 13 | 394.83K |
Turnover | 267.8K | 31.01B |
Average Price | 206 | 785.54 |
Value | 267.8K | 31.01B |
Indicative Equilibrium Price | — | 775 |
Indicative Equilibrium Volume | — | 145.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →